Palomar (PLMR) Expected to Announce Quarterly Earnings on Wednesday

Palomar (NASDAQ:PLMR) will likely be announcing its Q4 2025 results before the market opens on Wednesday, February 11th. Analysts expect the company to announce earnings of $2.06 per share and revenue of $204.58 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Thursday, February 12, 2026 at 12:00 PM ET.

Palomar (NASDAQ:PLMR) last released its quarterly earnings results on Thursday, November 6th. The company reported $2.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.56 by $0.45. The firm had revenue of $244.66 million for the quarter, compared to the consensus estimate of $207.98 million. Palomar had a return on equity of 21.93% and a net margin of 22.59%.During the same quarter last year, the business posted $1.23 EPS. On average, analysts expect Palomar to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Palomar Trading Down 1.2%

Shares of NASDAQ PLMR opened at $127.62 on Monday. Palomar has a twelve month low of $107.75 and a twelve month high of $175.85. The stock has a 50 day moving average of $127.78 and a two-hundred day moving average of $123.20. The stock has a market cap of $3.38 billion, a P/E ratio of 19.91 and a beta of 0.44.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Keefe, Bruyette & Woods lifted their target price on shares of Palomar from $170.00 to $171.00 and gave the company an “outperform” rating in a report on Tuesday, January 6th. Wall Street Zen lowered shares of Palomar from a “buy” rating to a “hold” rating in a research note on Saturday. Weiss Ratings raised shares of Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, January 14th. Finally, JPMorgan Chase & Co. raised their price target on Palomar from $145.00 to $155.00 and gave the stock an “overweight” rating in a report on Wednesday, January 7th. Six equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Palomar currently has a consensus rating of “Moderate Buy” and an average target price of $159.50.

Insider Buying and Selling

In related news, President Jon Christianson sold 515 shares of the firm’s stock in a transaction dated Saturday, January 31st. The shares were sold at an average price of $121.75, for a total value of $62,701.25. Following the completion of the sale, the president owned 65,421 shares in the company, valued at $7,965,006.75. This trade represents a 0.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO T Christopher Uchida sold 545 shares of Palomar stock in a transaction that occurred on Saturday, January 31st. The shares were sold at an average price of $121.74, for a total value of $66,348.30. Following the completion of the sale, the chief financial officer directly owned 14,005 shares in the company, valued at $1,704,968.70. This represents a 3.75% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 58,998 shares of company stock worth $7,255,669. 3.70% of the stock is currently owned by insiders.

Institutional Trading of Palomar

Institutional investors have recently modified their holdings of the business. CIBC Bancorp USA Inc. acquired a new position in Palomar during the third quarter worth $328,000. Danske Bank A S purchased a new stake in shares of Palomar during the 3rd quarter worth $9,503,000. Advisory Services Network LLC purchased a new stake in shares of Palomar during the 3rd quarter worth $57,000. Armistice Capital LLC acquired a new position in shares of Palomar during the 3rd quarter worth $299,000. Finally, CANADA LIFE ASSURANCE Co increased its holdings in shares of Palomar by 2.0% in the 3rd quarter. CANADA LIFE ASSURANCE Co now owns 27,439 shares of the company’s stock valued at $3,139,000 after purchasing an additional 538 shares in the last quarter. 90.25% of the stock is currently owned by hedge funds and other institutional investors.

About Palomar

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.